Firefly Neuroscience Inc (AIFF)

$1.73 +0.07 (4.22%)
Market Cap 21.71M
Revenue (ttm) 110,000.00
Net Income (ttm) -10.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,509.09%
Debt to Equity Ratio 0.00
Volume 95,100
Avg Vol 252,528
Day's Range N/A - N/A
Shares Out 13.48M
Stochastic %K 58%
Beta 1.88
Analysts Strong Buy
Price Target N/A

Company Profile

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serv...

Industry: Software - Application
Sector: Technology
Phone: 888 237 6412
Address:
1100 Military Road, Kenmore, United States
SJDodge
SJDodge Dec. 4 at 2:55 PM
$AIFF - I strongly believe that this mixed shelf is a strategic staging move for an incoming structural change - possibly merger, acquisition, or major partnership ... Acquirers often want the target to have up-to-date financing registration and flexibility...to me this is very Bullish given the sequence of events over past ~6months...
0 · Reply
SJDodge
SJDodge Dec. 3 at 4:48 PM
$AIFF - Liquidity is drying up - getting ready for a breakout or breakdown...My data indicates a breakout
1 · Reply
RoyalR
RoyalR Dec. 2 at 6:59 AM
$AIFF Will this ever reach 15$ again in Feb,2026??
2 · Reply
elgreg_2002
elgreg_2002 Nov. 28 at 9:28 PM
$AIFF Happy thanksgiving everyone even the shorts!
0 · Reply
elgreg_2002
elgreg_2002 Nov. 28 at 2:42 PM
$AIFF
0 · Reply
Twills08
Twills08 Nov. 25 at 9:12 PM
$AIFF $ALPS $ELBM $ZEO Took a starter in ELBM and ALPS. We will see what happens. Nice close ;)
0 · Reply
Twills08
Twills08 Nov. 25 at 1:38 PM
$AIFF $ALPS $ELBM $ZEO So far so good. Recs remain. ALPS and ELBM set to run this AM. I like it
0 · Reply
Twills08
Twills08 Nov. 24 at 10:55 AM
$AIFF $ALPS $ELBM $ZEO
1 · Reply
Twills08
Twills08 Nov. 22 at 2:41 PM
$AIFF $ALPS $ELBM $ZEO All of these have bottomed out, whether from dilution, awaiting a catalyst, or simply retail selling in the recent market drop. All of these have been prior runners excepting ALPS, which appears to be setting up for a massive move. AIFF, ELBM, and ZEO are in periods of accumulation prior to the same. Any one of these can run up 100% in hours/days. Take a look. DD, decide for yourself, and GLTY.
1 · Reply
elgreg_2002
elgreg_2002 Nov. 21 at 10:05 PM
$AIFF The Firefly narrative can only fly under the radar for so long! The total moving parts of the business model is expanding and the story is oh so much overlooked! Firefly is a 🔥 short fuse to a technology inevitably!
0 · Reply
Latest News on AIFF
Firefly Neuroscience Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 7:45 AM EST - 23 days ago

Firefly Neuroscience Reports Third Quarter 2025 Financial Results

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

Sep 5, 2025, 7:55 AM EDT - 3 months ago

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform

Aug 26, 2025, 7:45 AM EDT - 3 months ago

Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Jul 14, 2025, 7:45 AM EDT - 5 months ago

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Firefly Neuroscience to be Added to the Russell Microcap® Index

Jun 23, 2025, 8:05 AM EDT - 5 months ago

Firefly Neuroscience to be Added to the Russell Microcap® Index

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

Jun 20, 2025, 7:45 AM EDT - 6 months ago

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

May 5, 2025, 9:00 PM EDT - 7 months ago

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

May 5, 2025, 7:45 AM EDT - 7 months ago

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Mar 6, 2025, 7:30 AM EST - 9 months ago

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Feb 21, 2025, 8:00 AM EST - 10 months ago

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Firefly Neuroscience Accepted into NVIDIA Connect Program

Feb 11, 2025, 7:45 AM EST - 10 months ago

Firefly Neuroscience Accepted into NVIDIA Connect Program

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Feb 7, 2025, 7:30 AM EST - 10 months ago

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Jan 14, 2025, 12:25 PM EST - 11 months ago

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Jan 14, 2025, 7:45 AM EST - 11 months ago

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Dec 31, 2024, 9:00 AM EST - 1 year ago

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Nov 14, 2024, 5:30 PM EST - 1 year ago

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Nov 6, 2024, 9:00 AM EST - 1 year ago

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 25, 2024, 4:10 PM EDT - 1 year ago

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Oct 16, 2024, 9:20 AM EDT - 1 year ago

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Oct 11, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Sep 10, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Aug 26, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

Aug 21, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

Aug 13, 2024, 4:06 PM EDT - 1 year ago

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

SJDodge
SJDodge Dec. 4 at 2:55 PM
$AIFF - I strongly believe that this mixed shelf is a strategic staging move for an incoming structural change - possibly merger, acquisition, or major partnership ... Acquirers often want the target to have up-to-date financing registration and flexibility...to me this is very Bullish given the sequence of events over past ~6months...
0 · Reply
SJDodge
SJDodge Dec. 3 at 4:48 PM
$AIFF - Liquidity is drying up - getting ready for a breakout or breakdown...My data indicates a breakout
1 · Reply
RoyalR
RoyalR Dec. 2 at 6:59 AM
$AIFF Will this ever reach 15$ again in Feb,2026??
2 · Reply
elgreg_2002
elgreg_2002 Nov. 28 at 9:28 PM
$AIFF Happy thanksgiving everyone even the shorts!
0 · Reply
elgreg_2002
elgreg_2002 Nov. 28 at 2:42 PM
$AIFF
0 · Reply
Twills08
Twills08 Nov. 25 at 9:12 PM
$AIFF $ALPS $ELBM $ZEO Took a starter in ELBM and ALPS. We will see what happens. Nice close ;)
0 · Reply
Twills08
Twills08 Nov. 25 at 1:38 PM
$AIFF $ALPS $ELBM $ZEO So far so good. Recs remain. ALPS and ELBM set to run this AM. I like it
0 · Reply
Twills08
Twills08 Nov. 24 at 10:55 AM
$AIFF $ALPS $ELBM $ZEO
1 · Reply
Twills08
Twills08 Nov. 22 at 2:41 PM
$AIFF $ALPS $ELBM $ZEO All of these have bottomed out, whether from dilution, awaiting a catalyst, or simply retail selling in the recent market drop. All of these have been prior runners excepting ALPS, which appears to be setting up for a massive move. AIFF, ELBM, and ZEO are in periods of accumulation prior to the same. Any one of these can run up 100% in hours/days. Take a look. DD, decide for yourself, and GLTY.
1 · Reply
elgreg_2002
elgreg_2002 Nov. 21 at 10:05 PM
$AIFF The Firefly narrative can only fly under the radar for so long! The total moving parts of the business model is expanding and the story is oh so much overlooked! Firefly is a 🔥 short fuse to a technology inevitably!
0 · Reply
SJDodge
SJDodge Nov. 21 at 7:19 PM
$AIFF - Prob close around $1.65 - these MM's are becoming predictable...
1 · Reply
SJDodge
SJDodge Nov. 19 at 4:41 PM
$AIFF
0 · Reply
Snookville
Snookville Nov. 19 at 4:20 PM
$AIFF This looks pretty juicy here for long-term hold. Beastly application of tech.
1 · Reply
SJDodge
SJDodge Nov. 18 at 10:58 PM
$AIFF - Appears she has finally bottomed out... raising of the authorized shares 50x alone brought uncertainty until company announces next steps - Investors are sitting and waiting - scared of massive dilution. Plus, Arena unloaded 800K shares & WPC unloaded 500K all in Oct. Now - we need to see value added reasoning of the 50X increase in authorized shares - good news and this will 2-3X.
0 · Reply
elgreg_2002
elgreg_2002 Nov. 18 at 8:55 PM
$AIFF What we witnessed the last two weeks of stock price destruction was largely driven by algorithmic trades relentlessly compressing the share price! There are many reasons for this occurrence and a conspiracy is not one of the likely explanations . These relentless step downs in price over many day are common in micro stocks! Its arguably the hardest thing for a small investor to endure (irrational price volatility) Thats where reason and not fear rule the trade! If your thesis remains intact so should your investment! This is a developing story and it’s going to take time for it to play out! But, the pieces are in place for Firefly to become a must have technology for pharmaceutical research, neurology clinicians, behavioral health, as a must have intervention tool for identifying early a host of neurological degenerative disorders! We stockholders are approaching an inflection point where validation commands attention! GLT
0 · Reply
Trinity031983
Trinity031983 Nov. 18 at 7:15 PM
$AIFF 4. Index Inclusion Effects: Added to the Russell Microcap® Index in June 2025, less than a year post-Nasdaq listing.  This could attract passive ETF inflows or institutional interest, especially if AIFF maintains compliance and shows growth.
0 · Reply
Trinity031983
Trinity031983 Nov. 18 at 7:14 PM
$AIFF 3. Partnership Expansions and Collaborations: • Ongoing ties with Bright Minds Bioscience for epilepsy/DEE trials (Phase 2 collaboration announced October 2024).  • Nvidia Partner Connect Program entry in February 2025 caused a 200%+ surge; further AI integrations or joint announcements could reignite interest.   • New deals like with NCD for BNA™ in patient protocols (September 2025) and potential genetic research breakthroughs.   Watch for PR on clinical data or expanded use in Alzheimer’s screening via EEG/BNA™.
0 · Reply
Trinity031983
Trinity031983 Nov. 18 at 7:14 PM
$AIFF Near-Term Catalysts (Next 1–3 Months) 2. Integration of Recent Acquisition (Evoke Neuroscience): AIFF acquired Evoke for $6M in September 2025 (50% cash, 50% stock at $3.50/share), adding EEG hardware and expanding its neurotech ecosystem.  Successful integration could lead to new revenue streams from combined BNA™ + Evoke tech, with updates potentially in early 2026 filings or PR. This has been highlighted as a growth driver in investor discussions.
0 · Reply
Trinity031983
Trinity031983 Nov. 18 at 7:12 PM
$AIFF Near-Term Catalysts (Next 1–3 Months) 1. Upcoming Earnings and Financial Updates: AIFF’s Q3 2025 earnings showed explosive revenue growth of 1,075% YoY and a 25.11% narrowing of net losses, signaling operational progress.  The next quarterly report (Q4 2025, expected late February/early March 2026) could build on this if revenue from BNA™ integrations continues to ramp. Positive surprises in cash burn reduction or guidance could spark short-term rallies, especially with the stock trading near lows.
0 · Reply
JayBirdEvans
JayBirdEvans Nov. 18 at 6:24 PM
$IBIO and $AIFF
0 · Reply
topstockalerts
topstockalerts Nov. 18 at 1:01 PM
Pre Market Top Gainers $OLMA $ASBP $HTLM $GRAN $AIFF
0 · Reply
topstockalerts
topstockalerts Nov. 18 at 11:41 AM
Pre Market Top Gainers PT2 $AIFF $RYET $ICU $CLIK $GRRR
0 · Reply